DNLI
Denali Therapeutics Inc.
$16.28
-$0.10(-0.61%)
71
Overall
60
Value
83
Tech
--
Quality
Market Cap
$2.44B
Volume
1.24M
52W Range
$10.57 - $33.33
Target Price
$31.60
Key Metrics Overview
| Market Cap | $2.44B | P/E Ratio | N/A |
| 52W High | $33.33 | 52W Low | $10.57 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -2.5% | 52W Position | 25.1% |
| Overall Score | 71 | Value Score | 60 |
| Quality Score | -- | Technical Score | 83 |
Growth Analysis
| EPS Current Est | $-3.04 | EPS Next Est | $-2.93 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNLI | $16.28 | -0.6% | 1.24M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Denali Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW